<DOC>
	<DOCNO>NCT00493974</DOCNO>
	<brief_summary>Chronic obstructive pulmonary disease ( COPD ) long-term lung disease cause cigarette smoking breathe lung irritant , include pollution , dust , chemical . The purpose study evaluate effectiveness zileuton , medication use control asthma symptom , reduce length hospital stay adult hospitalize COPD exacerbation , worsen COPD symptom .</brief_summary>
	<brief_title>Zileuton Treat Adults With Chronic Obstructive Pulmonary Disease ( The LEUKO Study )</brief_title>
	<detailed_description>COPD disease lung airways partly damage obstruct , make difficult breathe . COPD fourth lead cause death United States . Symptoms include cough , excess mucus production , shortness breath , wheeze , chest tightness . Treatment usually include inhaled bronchodilator steroid medication work relax muscle around lung airway reduce inflammation . Zileuton , medication use prevent asthma symptom , may beneficial treat people experience COPD exacerbation . Zileuton work block formation substance cause inflammation , fluid retention , constriction lung . The purpose study evaluate effectiveness zileuton reduce length hospital stay adult hospitalize COPD exacerbation . This study enroll adult admit hospital due severe COPD symptom . Participants randomly assign receive either zileuton placebo four time day 14 day . While hospital , lung function test urine collection occur . Study visit occur Days 14 30 , include lung function testing , medical history review , study drug adverse effect review .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Zileuton</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Admitted hospital COPD exacerbation FEV1 le 60 % predict level At least 10 pack year smoke Any uncontrolled systemic disease Known hypersensitivity zileuton Asthma Lobar pneumonia pulmonary edema Interstitial lung disease Medical condition likely limit survival le 30 day time study entry History liver disease Current use theophylline Participation another clinical trial COPD Clinical Research Network Incarceration Institutionalization Pregnant History suicide attempt Prior inpatient admission psychiatric disorder Bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Anti-leukotriene</keyword>
	<keyword>Length Stay</keyword>
	<keyword>LOS</keyword>
</DOC>